Lactobacillus rhamnosus
Useful mainly for preventing antibiotic-associated diarrhea and shortening acute diarrhea in children.
Quick decision guide
May help most
preventing antibiotic-associated diarrhea and shortening acute diarrhea in children
Common dosing range
5–20 billion CFU/day (10–20 billion twice daily for acute diarrhea)
When to expect effects
Days for diarrhea uses
Watch out for
Rare bacteremia risk in the severely immunocompromised
What is it
Lactobacillus rhamnosus (recently reclassified as Lacticaseibacillus rhamnosus) is a probiotic bacterium widely used in supplements and fermented foods. It is one of the most extensively studied probiotic strains, with research focused on gut, immune, and women's health applications.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
acute infectious diarrhea (children) Good Evidence | About a day shorter | children with acute infectious gastroenteritis | Days |
atopic dermatitis prevention (high-risk infants) Good Evidence | Modest risk reduction | high-risk infants, with maternal/infant supplementation (notably HN001) | Months |
bacterial vaginosis and urogenital health Limited Evidence | Uncertain | women seeking adjunct urogenital support | Weeks |
irritable bowel syndrome Limited Evidence | Small | adults with IBS willing to trial a probiotic | Weeks |
acute infectious diarrhea (children)
- Effect
- About a day shorter
- Best fit
- children with acute infectious gastroenteritis
- Time
- Days
atopic dermatitis prevention (high-risk infants)
- Effect
- Modest risk reduction
- Best fit
- high-risk infants, with maternal/infant supplementation (notably HN001)
- Time
- Months
bacterial vaginosis and urogenital health
- Effect
- Uncertain
- Best fit
- women seeking adjunct urogenital support
- Time
- Weeks
irritable bowel syndrome
- Effect
- Small
- Best fit
- adults with IBS willing to trial a probiotic
- Time
- Weeks
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
acute infectious diarrhea (children)
Disease adjunctMeta-analyses show L. rhamnosus GG modestly shortens the duration of acute infectious diarrhea in children, typically by around a day, alongside rehydration. Higher doses (10–20 billion CFU twice daily) have been studied. It complements, not replaces, oral rehydration.
Bottom line: Reliably shortens childhood acute diarrhea by roughly a day as an adjunct to rehydration.
atopic dermatitis prevention (high-risk infants)
Disease adjunctTrials, particularly of strain HN001 given in pregnancy and early infancy, suggest a reduced incidence of eczema in high-risk infants. Results are strain-specific and not uniform across studies. The effect is modest.
Bottom line: Specific strains (e.g. HN001) may modestly cut eczema risk in high-risk infants.
Evidence is mixed
Benefit is strain- and timing-specific; some trials show reduced eczema while others do not.
bacterial vaginosis and urogenital health
Disease adjunctSome trials suggest L. rhamnosus, often with L. reuteri, may help restore vaginal flora and support treatment of bacterial vaginosis. Evidence is mixed and strain- and protocol-dependent. It is at best an adjunct to standard therapy.
Bottom line: Possible adjunct for urogenital health, but evidence is limited and inconsistent.
Evidence is mixed
Urogenital trials vary in strains, routes, and outcomes, with inconsistent results.
irritable bowel syndrome
Disease adjunctProbiotic trials including L. rhamnosus report small, inconsistent improvements in IBS symptoms. Strain-specific effects make general conclusions difficult, and L. rhamnosus is not the best-supported strain for IBS. A time-limited trial is reasonable.
Bottom line: May modestly help some IBS symptoms, but evidence is limited and strain-dependent.
Evidence is mixed
IBS probiotic trials are heterogeneous and strain-specific, with mixed results.
How it works
How to take it
What to track
3 commercial forms
Compare the main delivery options and what they’re best suited for.
L. rhamnosus GG (LGG)
Patented strain found in many branded probiotic products. Strongest evidence for acute diarrhea and antibiotic-associated diarrhea.
Most-studied strain, well-documented gut adhesion
L. rhamnosus HN001
Used in prenatal and infant probiotic products, with research on eczema prevention and gestational diabetes.
Studied in pregnancy and infant trials
L. rhamnosus GR-1
Studied for vaginal and urinary tract health, typically in combination with other strains.
Often combined with L. reuteri RC-14 for urogenital use
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Rare bacteremia in immunocompromised people, those with central venous catheters, or critically ill patients
Who should avoid it
- Severely immunocompromised people (chemotherapy, transplant on immunosuppression)
- People with central venous catheters
- Premature infants except under specialist supervision
Pregnancy & breastfeeding
Generally well tolerated; specific strains (e.g. HN001) have been studied in pregnancy.
Interactions
Can kill the probiotic; separate doses by at least 2 hours
May raise the small risk of infection from live bacteria
Food sources
| Food | Amount | %DV |
|---|---|---|
| Yogurt (some brands with added cultures) | Varies; typically 10^6 to 10^9 CFU per serving | — |
| Kefir | Multi-strain fermented milk; CFU varies | — |
| Fermented cheeses (aged) | Variable presence; not standardized | — |
Yogurt (some brands with added cultures)
- Amount
- Varies; typically 10^6 to 10^9 CFU per serving
- %DV
- —
Kefir
- Amount
- Multi-strain fermented milk; CFU varies
- %DV
- —
Fermented cheeses (aged)
- Amount
- Variable presence; not standardized
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Does the specific strain of L. rhamnosus matter?⌄
Yes. Strain-specific effects mean that studies on L. rhamnosus GG do not necessarily apply to other strains. Look for the specific strain designation (like 'GG' or 'HN001') if you're targeting a specific health goal.
Can I take L. rhamnosus while on antibiotics?⌄
Yes. Taking L. rhamnosus during a course of antibiotics may reduce the risk of antibiotic-associated diarrhea. Separate doses from the antibiotic by at least 2 hours.
How long until I notice effects?⌄
For acute conditions like diarrhea, effects may be seen within days. For chronic concerns like IBS or eczema prevention, several weeks to months of consistent use are typically needed.
Do I need to refrigerate L. rhamnosus?⌄
Most live probiotic supplements benefit from refrigeration to maintain CFU count, but some products are shelf-stable. Always check the label.
Is L. rhamnosus safe in pregnancy?⌄
Studies have used L. rhamnosus, including HN001, during pregnancy without apparent harm. Discuss with your obstetric provider before starting any supplement during pregnancy.
References by claim
acute infectious diarrhea (children)
atopic dermatitis prevention (high-risk infants)
bacterial vaginosis and urogenital health
Track Lactobacillus rhamnosus with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.